Trileptal

We don't have all the answers yet, but one direct result of the week was that her doctor has finally pulled her off Trileptal, which is possibly the worst drug ever.

Ann Richards, R.I.P. yendi 2006

If a medication, such as Trileptal (one of six illegally marketed Novaritis drugs) is approved for seizures, it cannot be marketed for chronic pain.

Mark Hyman, MD: Science for Sale: Protect Yourself From Medical Research Deception MD Mark Hyman 2010

If a medication, such as Trileptal (one of six illegally marketed Novaritis drugs) is approved for seizures, it cannot be marketed for chronic pain.

Mark Hyman, MD: Science for Sale: Protect Yourself From Medical Research Deception MD Mark Hyman 2010

If a medication, such as Trileptal (one of six illegally marketed Novaritis drugs) is approved for seizures, it cannot be marketed for chronic pain.

Mark Hyman, MD: Science for Sale: Protect Yourself From Medical Research Deception MD Mark Hyman 2010

A Novartis subsidiary in the U.S. has agreed to pay $422.5 million to resolve criminal and civil charges that it illegally marketed the epilepsy drug Trileptal and five other drugs.

Business Watch 2010

Prosecutors alleged Novartis promoted Trileptal for off-label uses such as the treatment of pain and bipolar disease.

Novartis Unit Settles U.S. Charges Over Marketing Brent Kendall 2010

Novartis Pharmaceuticals, for example, agreed to pay $420 million after its owners pleaded guilty to the illegal marketing Trileptal, a medication approved for epilepsy, as a psychiatric and pain medication.

$2.5 billion won in health care fraud cases 2011

The company will pay another $237.5 million to resolve civil allegations that it promoted Trileptal for uses that weren't medically accepted.

Novartis Unit Settles U.S. Charges Over Marketing Brent Kendall 2010

WASHINGTON — A U.S. subsidiary of Swiss drug maker Novartis AG agreed to pay $422.5 million to resolve criminal charges and civil allegations that it illegally marketed the epilepsy drug Trileptal and paid kickbacks to doctors to prescribe its medicines.

Novartis Unit Settles U.S. Charges Over Marketing Brent Kendall 2010

They alleged Novartis profited by hundreds of millions of dollars through the misbranding and off-label promotion of Trileptal.

Novartis Unit Settles U.S. Charges Over Marketing Brent Kendall 2010